Ocular complications of childhood rheumatic diseases: nonuveitic inflammatory eye diseases.
Ocular involvement is common in pediatric rheumatologic diseases, supporting the concept that these conditions do not manifest in isolation but are components of a multisystem inflammatory process. It remains unclear why the eye and its adjacent tissues become a target during paninflammatory disease. Pediatric rheumatologists must recognize ocular disorders, as these conditions significantly concern the treatment team managing serious cases of inflammatory eye disease. Close collaboration between the treating rheumatologist and ophthalmologist is required to prevent potentially devastating outcomes. Therapeutic interventions, such as topical steroids, systemic immunosuppressants, and biologics, must balance the necessity of controlling ocular inflammation and treatment-related adverse effects. This article-the second in a series on ocular complications of childhood rheumatic diseases-reviews the presentation and management of the more common nonuveitic inflammatory ocular manifestations of childhood rheumatologic disease.
Reiff
Andreas
A
Division of Rheumatology, Childrens Hospital Los Angeles, 4650 Sunset Boulevard, Mailstop 60, Los Angeles, CA 90027 USA. reiff@hsc.usc.edu
D018501:Antirheumatic Agents / Q000009:adverse effects; D001171:Arthritis, Juvenile / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D002648:Child; D005128:Eye Diseases / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D006801:Humans; D012216:Rheumatic Diseases / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D014657:Vasculitis / Q000150:complications / Q000188:drug therapy / Q000473:pathology
D018501:Antirheumatic Agents